1. Home
  2. ARBB vs NXL Comparison

ARBB vs NXL Comparison

Compare ARBB & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

N/A

Current Price

$4.05

Market Cap

7.6M

Sector

Technology

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

N/A

Current Price

$1.64

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBB
NXL
Founded
1997
2010
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
7.5M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
ARBB
NXL
Price
$4.05
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
★ 2.0M
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.76
EPS
★ N/A
N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
$57.09
$14.37
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$3.65
$0.22
52 Week High
$10.67
$96.00

Technical Indicators

Market Signals
Indicator
ARBB
NXL
Relative Strength Index (RSI) 37.63 29.10
Support Level N/A $0.22
Resistance Level $4.95 $5.36
Average True Range (ATR) 0.21 0.31
MACD -0.03 0.06
Stochastic Oscillator 17.95 1.84

Price Performance

Historical Comparison
ARBB
NXL

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: